G. Woolthuis

Treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone is beneficial but toxic in very elderly patients with diffuse large B-cell lymphoma: a population-based cohort study on treatment, toxicity and outcome

H. Kluin-Nelemans, E. V. van Roon, H. Storm, 2014, Leukemia & lymphoma.

Tolerance and efficacy of amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients

W. Sluiter, B. Pauw, Z. Erjavec, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Combination therapy with bortezomib, continuous low‐dose cyclophosphamide and dexamethasone followed by one year of maintenance treatment for relapsed multiple myeloma patients

E. Vellenga, L. Munck, M. Hoogendoorn, 2015, British journal of haematology.

No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status.

H. Kluin-Nelemans, G. D. de Bock, E. V. van Roon, 2017, Cancer epidemiology.

The role of initial clinical presentation, comorbidity and treatment in multiple myeloma patients on survival: a detailed population-based cohort study

B. Rees, H. Storm, N. Veeger, 2017, European Journal of Clinical Pharmacology.